• Jobs
  • Startups
  • Hire
LoginSign up

Cleerly

Cleerly has 6 open roles, 1 posted in the last 30 days. Stated pay range: $125k – $192k a year. Funding stage: Series C. Last round: $106M, Dec 4, 2024.

Open roles

  • Cleerly logo
    Sr. Product Designer

    Cleerly

    • Virtual US
    • Senior
    • $167k–$192k
    AI-native
    cleerly.com
    Posted 26d ago
  • Cleerly logo
    Regional Sales Manager, Health Systems (NYC)

    Cleerly

    • New York, NY
    • Senior
    • $140k–$150k
    cleerly.com
    Posted 35d ago
  • Cleerly logo
    Cloud Security Engineer

    Cleerly

    • Virtual US
    • Senior
    • $125k–$175k
    cleerly.com
    Posted 50d ago
  • Cleerly logo
    Regional Sales Manager, Health Systems (Philadelphia)

    Cleerly

    • Philadelphia, PA
    • Senior
    • $140k–$150k
    cleerly.com
    Posted 64d ago
  • Cleerly logo
    Regional Sales Manager, Health Systems (Houston)

    Cleerly

    • Houston, TX
    • Senior
    • $140k–$150k
    cleerly.com
    Posted 70d ago
  • Cleerly logo
    Clinical Account Manager (Tennessee/North Carolina)

    Cleerly

    • Charlotte, NC
    • Senior
    • $130k–$140k
    cleerly.com
    Posted 193d ago

About

Cleerly logo

Cleerly

Personalized precision heart health

Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, Cleerly supports comprehensive phenotyping of coronary artery disease, through its evaluation of advanced non-invasive CT imaging. Cleerly’s approach is grounded in nearly 20 years of science from landmark multi-center clinical trials. Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.

Private companySeries CIn the news
Founded2017
HQDenver, United States
Size355 employees
Unlock human wisdom
ThesisTermsPrivacy
Industry
Medical Equipment Manufacturing
Funding
  • Series C · $106M · Dec 4, 2024
Investors
Insight PartnersBattery Ventures
News
  • PARAMOUNT, the First Randomized Trial of AI-Enabled Plaque-Based Care, Meets Primary Endpoint in Late-Breaking Results at AHA 2026
  • Cleerly to Present Late-Breaking Results from the First Randomized Trial of AI-QCT-Guided Care in Patients with Stable Chest Pain at AHA 2026
  • Cleerly to Present Late-Breaking Results from the First Randomized Trial of AI-QCT-Guided Care in Patients with Stable Chest Pain at AHA 2026

Claim cleerlyhealth.com

Work at cleerlyhealth.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.